• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconValeant

Valeant

Page 3 of 12
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health
T. Rowe Price Sues Valeant Over Alleged Fraud
By Sy MukherjeeAugust 18, 2016
Here’s Why Shares of Valeant are Soaring
Finance
Here’s Why Shares of Valeant are Soaring
By Lucinda ShenAugust 17, 2016
Berkshire Hathaway Inc. Annual General Meeting
Finance
How Valeant Defies the Warren Buffett School of Investing
By Jen WiecznerAugust 11, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance
Valeant Executives May Be Facing Criminal Prosecution
By ReutersAugust 10, 2016
Squawk Box - Season 20
Finance
Bill Ackman Met Big Investors About Valeant at a Private Brainstorming Dinner
By ReutersAugust 10, 2016
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
Finance
Valeant’s Troubles Aren’t Driving It To Lower Drug Prices
By Jen WiecznerAugust 9, 2016
Valeant’s CEO Says He Is Not Actively Shopping Core Assets
Health
Valeant’s CEO Says He Is Not Actively Shopping Core Assets
By ReutersAugust 9, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
Health
Here’s Why Shares of Valeant Are Jumping
By ReutersAugust 9, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
Finance
Widely Loathed Valeant Pharmaceuticals Gets New Top Lawyer and PR Exec
By ReutersAugust 8, 2016
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
Health
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
By Sy MukherjeeAugust 1, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Health
The FDA Sees a Problem with Valeant’s New Glaucoma Eye Drops
By ReutersJuly 22, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Investors Pull $600M After Ackman’s Bad Bets
By Michelle CelarierJuly 19, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Former Valeant CEO Michael Pearson Just Sold About Five Million Shares of the Company
By Lucinda ShenJuly 13, 2016
PETA protesters against the use of meat blocked Re
Finance
Valeant’s Second Largest Investor Just Dumped the Rest of Its Stock
By Lucinda ShenJuly 13, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
Health
New Valeant CEO Meets Investors Amid Company Struggles
By ReutersJune 14, 2016
1
  • 1
  • 2
  • 3
  • 4
  • 5
...12
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.